Multiple Sclerosis News Today

Multiple Sclerosis News Today Your source for multiple sclerosis news, support, & real stories from the community. Let’s raise multiple sclerosis awareness together!🎗️

Multiple Sclerosis News Today is a leading online health, science, and research publication, focused on delivering daily news and information about MS to those affected by the disease, as well as providing first-hand perspectives from members of the patient community. Our news and information articles are written by a dedicated team of science writers, curated, fact-checked, and edited by a team o

f PhD researchers and experienced journalists whose sole focus is ensuring our news and information is accurate, timely, relevant, and easy to understand. Our columns are written by MS patients and caregivers who provide an intimate look at what it’s like to live with MS. Their stories offer a realistic first-hand account of various aspects of the disease, in addition to providing inspiration and hope to our patient communities. We also offer audio content, via our audio news briefings and The Multiple Sclerosis Podcast, hosted by MS patient and advocate Jenn Powell. MS News Today also hosts forums, where members of the community can connect with one another.

🧡 Managing life with MS isn’t just about managing symptoms—it’s about caring for your whole self. https://bit.ly/3JGrn1u...
11/25/2025

🧡 Managing life with MS isn’t just about managing symptoms—it’s about caring for your whole self. https://bit.ly/3JGrn1u

☀️ Strategies like building a support network, practicing mindfulness, and offering yourself compassion can strengthen your emotional well-being when living with multiple sclerosis.

🌸 You’re not alone—and every step you take toward nurturing your mental health matters.

Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression ...
11/25/2025

Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in people with MS https://buff.ly/zA5CjjW

🧡 Caring for someone with SPMS doesn’t just mean adapting to physical changes — it’s also emotional. Over time, symptoms...
11/25/2025

🧡 Caring for someone with SPMS doesn’t just mean adapting to physical changes — it’s also emotional. Over time, symptoms like stiffness, coordination issues, fatigue, and cognitive challenges may become more common.

Take a closer look at what to expect: https://bit.ly/3LPHlru

Columnist Ahna Crum enjoys quieter holidays that don't overstimulate, because living with MS means needing to head off n...
11/25/2025

Columnist Ahna Crum enjoys quieter holidays that don't overstimulate, because living with MS means needing to head off neurological overload. https://buff.ly/o3cyrCA

From disease-modifying therapies to symptom management strategies, there’s more than one path forward. https://bit.ly/45...
11/24/2025

From disease-modifying therapies to symptom management strategies, there’s more than one path forward. https://bit.ly/45oE6x4

Jeremiah Robison, Founder and CEO of CIONIC, is a leader in advancing human mobility. His personal journey, deeply impac...
11/24/2025

Jeremiah Robison, Founder and CEO of CIONIC, is a leader in advancing human mobility. His personal journey, deeply impacted by his daughter's cerebral palsy diagnosis, led him to establish Cionic in 2018. His bold vision for the company is to leverage software, hardware, and machine learning to restore movement throughout the human body, beginning with walking. https://bit.ly/48dQ9yH

Join them as they delve into the Neural Sleeve 2, which has been recognized by Time Magazine as one of the greatest inventions of 2025 for the second time. They will discuss what motivated Cionic to develop the second-generation Neural Sleeve and its significant impact on individuals facing mobility challenges.

🔬 Genentech’s experimental MS drug fenebrutinib just hit a major milestone: in Phase III trials, it significantly reduce...
11/24/2025

🔬 Genentech’s experimental MS drug fenebrutinib just hit a major milestone: in Phase III trials, it significantly reduced relapse rates in relapsing MS and helped slow disability in primary progressive MS. https://bit.ly/4od1IfF

A Phase 2 clinical trial testing PIPE-307, an MS experimental therapy designed to promote myelin repair, failed to meet ...
11/24/2025

A Phase 2 clinical trial testing PIPE-307, an MS experimental therapy designed to promote myelin repair, failed to meet its efficacy goals. https://buff.ly/CB7OBK8

Address

Dallas, TX

Website

Alerts

Be the first to know and let us send you an email when Multiple Sclerosis News Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category